Tanzania sees good progress in the construction of medical products factory at Mloganzila industria Park

DAR ES SALAAM: THE National Task Force for Accelerating Investment in Medical Products Manufacturing (PIAT) has expressed satisfaction with progress in establishing medical products factories at the Mloganzila Industrial Park in Dar es Salaam, with production of approximately 60 per cent of medical equipment expected to begin in May 2027.

The development follows a visit by the task force to the industrial park, led by Minister for Health Mohamed Mchengerwa, to assess investment progress and preparations for the commencement of local medical products manufacturing.

Speaking during the visit, Mr Mchengerwa emphasised that Tanzania offers a reliable market for medical products, alongside significant opportunities across the East and Southern African regions. He urged investors to take advantage of these opportunities by establishing and expanding manufacturing industries in the country.

For his part, Deputy Permanent Secretary for Pharmaceutical Industries Emmanuel Tayari said all plots within the industrial park had already been allocated to investors, who had submitted their respective project implementation plans.

He added that Hongyu Company, which has significant capacity to manufacture medical equipment and supply the European market, was finalising construction of buildings that will accommodate medical equipment manufacturing facilities in Tanzania.

ALSO READ: Chinese firm eyes to invest in Tanzania’s Mloganzila medical devices hub

Located in Ubungo District, Dar es Salaam, the Mloganzila Industrial Park was officially launched on May 8, 2026, covering approximately 450 acres. The park is part of the government’s efforts to boost local production of medical products, reduce dependence on imports and improve the availability of medical supplies in the country.

PIAT comprises experts from the health, industry and investment sectors and operates under the supervision of the Ministry of Health. Its mandate is to coordinate and accelerate investment in medical products manufacturing industries to promote domestic production and strengthen the country’s health sector.